Sandoz Group AG - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
SDZNY Over the counter 2830 www.sandoz.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Sandoz Group AG

Sandoz (SWX:SDZ) Stock Could Be 36% Undervalued On Cash Flow - Oct 18th, 2026 11:14 am
NBIX vs. SDZNY: Which Stock Should Value Investors Buy Now? - Oct 13th, 2026 8:40 am
GRFS vs. SDZNY: Which Stock Should Value Investors Buy Now? - Sep 24th, 2026 8:40 am
What J&J’s Spravato patent win could mean for psychedelic drugs - Sep 24th, 2026 7:00 am
Podcast: How Sandoz plans to harness its “golden decade” - Sep 24th, 2026 5:22 am
Why Everyone Is Watching Sandoz Group (SWX:SDZ) Today - Sep 21st, 2026 11:11 am
Sandoz and mAbxience agree on emicizumab biosimilar partnership - Sep 21st, 2026 2:38 am
mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide - Sep 18th, 2026 4:28 am
“Unparalleled opportunity”: Sandoz embarks on ambitious biosimilar growth strategy - Sep 9th, 2026 5:19 am
GRFS or SDZNY: Which Is the Better Value Stock Right Now? - Sep 8th, 2026 9:40 am
Zacks Industry Outlook Highlights Amphastar Pharmaceuticals, Sandoz and Viatris - Aug 31st, 2026 9:10 am
3 Generic Drug Stocks to Watch Amid Improving Industry Trends - Aug 27th, 2026 11:06 am
AstraZeneca scores in lung cancer; Sandoz inks a China deal - Aug 18th, 2026 5:13 am
Sandoz targets industry patent void with $322m Henlius deal - Aug 17th, 2026 5:47 am